SA

Sushant Ambuj

Director Director DIN 10060168
DIN 10060168 First appointment Mar 2023 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Mar 2023
Shareholding value Locked Premium profile

About Sushant Ambuj

Sushant Ambuj has 3 years in corporate governance. Formerly with 1 company, such as Hexine Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 10060168
Primary Designation Director
First Appointment 01 Mar 2023
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

Company Designation Appointment Founded Status
Hexine Pharmaceuticals Private Limited U24290DL2022PTC402931
Director 01 Mar 2023 2022 Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Hexine Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Sushant Ambuj

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sushant Ambuj

Sushant Ambuj has 3 years in corporate governance. Formerly with 1 company, such as Hexine Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

Sushant Ambuj is associated with 0 companies as a director.

Sushant Ambuj has expertise in General Business.

Sushant Ambuj has 3 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available